A4LI H-SPAN Summit Washington, DC 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to A4LI H-SPAN Summit Washington, DC 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
A4LI H-SPAN Summit D.C. 2026
Date: April 14–16, 2026
Venue: Walter E. Washington Convention Center, Washington, D.C., USA
Event Type
The A4LI H-SPAN Summit is a leading symposium focusing on health, safety, policy, advocacy, and networking within the healthcare and public health sectors. It is designed to bring together top professionals, policymakers, and innovators to discuss the current landscape and future directions in health and safety policy.
Estimated Attendance
The summit is expected to draw over 5,000 attendees, including healthcare professionals, public health leaders, policymakers, and industry innovators.
1️⃣ Who Attends: Buyers / Attendees
The A4LI H-SPAN Summit attracts a diverse group of attendees, primarily from the healthcare and public health sectors. Buyers include public health policymakers, healthcare administrators, safety officers, and health advocacy leaders. The event is ideal for those involved in healthcare policy, safety regulations, and health advocacy initiatives.
- Healthcare administrators and policy makers
- Public health leaders and safety officers
- Health advocacy organizations
- Government health departments
- Medical technology and safety equipment manufacturers
2️⃣ Location + Attendee Geographic Origin
The summit will be held at the Walter E. Washington Convention Center in Washington, D.C., USA. Attendees will primarily come from across the United States, with a significant international presence due to the global relevance of health and safety issues.
Best Geographic Targeting:
- U.S.-based healthcare institutions and organizations
- International health policy organizations
- Global health advocacy networks
3️⃣ Audience Reach
The summit has a significant national and global reach, appealing to attendees from various sectors within the healthcare industry. It serves as a platform for cross-border collaboration on health and safety policy initiatives.
4️⃣ Sample Buyer Company Names + Websites
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Johnson & Johnson | jnj.com | Global Health Policy Director | Leader in healthcare products and initiatives; strong focus on health policy. |
| 2 | World Health Organization | who.int | Public Health Advisor | International influence on health policy and safety standards. |
| 3 | Kaiser Permanente | kp.org | Health Safety Officer | Major healthcare provider with a focus on safety and policy integration. |
| 4 | Centers for Disease Control and Prevention (CDC) | cdc.gov | Director of Public Health Initiatives | Key government agency in health safety and policy. |
| 5 | Medtronic | medtronic.com | Healthcare Solutions Manager | Leader in medical technology, focusing on health solutions and policy. |
| 6 | American Red Cross | redcross.org | Emergency Preparedness Coordinator | Focus on safety, emergency response, and health advocacy. |
| 7 | Pfizer | pfizer.com | Public Health Policy Manager | Global leader in pharmaceuticals with a strong public health focus. |
| 8 | GE Healthcare | gehealthcare.com | Director of Health Policy and Advocacy | Leader in healthcare technology and policy advocacy. |
| 9 | UnitedHealth Group | unitedhealthgroup.com | Health Policy Director | Major health services provider with a strong policy influence. |
| 10 | Boston Scientific | bostonscientific.com | Director of Health Safety | Innovator in medical technology focused on safety and policy. |
| 11 | National Institutes of Health (NIH) | nih.gov | Health Research Policy Manager | Key government institution for health research and policy. |
| 12 | Merck & Co. | merck.com | Director of Global Health Initiatives | Pharmaceutical leader with a focus on global health policy. |
| 13 | Becton, Dickinson and Company (BD) | bd.com | Safety and Policy Director | Specializes in medical devices and health safety solutions. |
| 14 | Roche | roche.com | Public Health Liaison | Focus on diagnostics and public health policy. |
| 15 | Abbott Laboratories | abbott.com | Healthcare Policy Advisor | Leader in health technology and policy advocacy. |
| 16 | Sanofi | sanofi.com | Health Advocacy Manager | Pharmaceutical company with a focus on health advocacy and policy. |
| 17 | Amgen | amgen.com | Director of Health Policy Strategy | Biotechnology leader with a focus on health policy. |
| 18 | Gilead Sciences | gilead.com | Public Health Strategy Manager | Biopharmaceutical company focused on public health strategies. |
| 19 | GlaxoSmithKline (GSK) | gsk.com | Health Policy Lead | Pharmaceutical leader with a strong focus on health policy. |
| 20 | AstraZeneca | astrazeneca.com | Director of Healthcare Policy Engagement | Global biopharmaceutical company with a strong policy focus. |
5️⃣ Job Profiles, Industries & Event Type
Best job profiles to target include:
- Director of Health Policy
- Public Health Advisor
- Healthcare Solutions Manager
- Safety and Policy Director
- Health Advocacy Manager
- Healthcare Policy Advisor
Industries represented at the event include:
- Healthcare
- Public Health and Safety
- Pharmaceuticals
- Medical Technology
- Health Advocacy
- Government Health Departments
6️⃣ Estimated Attendance / Expected Footfall
Estimated total attendance: 5,000+
This summit attracts a high footfall of professionals and decision-makers from the healthcare industry, focusing on policy, safety, and advocacy.
7️⃣ Key Focus Areas & Buyer Engagement
Key focus areas include:
- Health and safety policy development
- Public health advocacy and initiatives
- Healthcare technology advancements
- Emergency preparedness and response
- Global health initiatives and collaborations
Buyer engagement angle:
"We can help you connect with public health leaders, healthcare policy makers, safety officers, and industry innovators attending the A4LI H-SPAN Summit D.C. 2026."
8️⃣ Client-Product Fit Note
Please share your client website before finalizing the exact buyer list. The right buyers will vary based on the client product:
- If the client sells healthcare technology, target companies like GE Healthcare, Medtronic, and Boston Scientific.
- If the client focuses on pharmaceuticals, target companies like Pfizer, Merck & Co., and Sanofi.
- If the client offers health advocacy services, target organizations like the World Health Organization and American Red Cross.
9️⃣ Final Recommendation
This event is well-suited for attendee-list selling, with a focus on health policy, safety, and advocacy. Position it as a comprehensive database of healthcare policymakers, safety officers, and advocacy leaders.
Best buyer segments to collect include:
- Public health policymakers
- Healthcare safety officers
- Health advocacy leaders
- Industry innovators and policymakers
Quality rating for B2B attendee-list sales: 9/10
This is a strong event with national and global reach, attracting key decision-makers in health policy and safety.
A4LI H-SPAN Summit D.C. 2026
Event Profile, Buyer/Attendee Intelligence & Apollo Targeting Guide
1. About Area - Event Details
|
Field |
Details |
|
Event name |
A4LI H-SPAN Summit D.C. 2026 / H-SPAN Summit D.C. |
|
Dates |
June 29 - July 1, 2026 |
|
Venue |
Georgetown University Capitol Campus; Day 3 includes Congressional Briefing & Members Hill Day on Capitol Hill. |
|
City |
Washington, D.C. |
|
State / Region |
District of Columbia |
|
Country |
United States |
|
Event category from required list |
Medical & Pharma; Science & Research; Education & Training; Business Services; Wellness, Health & Fitness |
|
Event type |
Policy-focused longevity science summit, advocacy forum, biotech/research leadership meeting, and Capitol Hill engagement program. |
|
Organizer |
Alliance for Longevity Initiatives (A4LI), in partnership with Georgetown University Medical Center for the 2026 summit. |
|
Official positioning |
Third annual D.C. Summit bringing together leaders, advocates and innovators from around the globe to advance legislative initiatives that promote healthier human lifespan. |
|
Core agenda themes |
Day 1: Scientific Advancement in the Longevity Landscape. Day 2: Policy levers and frameworks for longevity innovation. Day 3: Congressional briefing and Capitol Hill meetings. |
|
Estimated attendance / footfall |
Official public pages do not publish a total attendance number. Recommended planning estimate: boutique policy summit of roughly 150-300 in-person senior attendees, plus sponsor/VIP/Hill Day participants. Mark as estimated until A4LI releases final numbers. |
2. Who Attends - Buyers / Attendees
|
Attendee Segment |
Profile |
|
Primary buyers / decision influencers |
Longevity biotech founders and CEOs, pharma/biotech BD leaders, policy and government affairs executives, research institute leaders, health-policy advocates, life-science investors, federal affairs teams, and sponsor companies seeking access to longevity policy stakeholders. |
|
Government / policy audience |
Members/staff connected to health policy, aging policy, Congressional offices, government health agencies, public health policy groups, longevity science caucus stakeholders, and advocacy coalition partners. |
|
Scientific audience |
Researchers in geroscience, aging biology, cellular therapy, biomarkers, AI drug discovery, clinical translation, regenerative medicine, chronic disease prevention, and public health innovation. |
|
Industry audience |
Longevity biotech, pharmaceutical innovation, healthtech, diagnostics, AI/biotech, clinical-stage therapeutics, nonprofits, foundations, patient-access and policy organizations. |
|
Buyer intent |
Policy influence, partnership development, sponsorship, scientific credibility, federal-access strategy, investor networking, BD discussions, advocacy alignment, and Hill Day relationship building. |
|
Non-buyer attendees |
Students, general enthusiasts and early-career advocates may be present, but paid list samples should prioritize senior executives, policy directors, scientific founders, investors and government affairs leaders. |
3. Where the Show is Happening + Attendee Geographic Origin
|
Geography |
Details |
|
Host market |
Washington, D.C., with activities centered around Georgetown University Capitol Campus and Capitol Hill. This is a policy-access location rather than a traditional expo hall market. |
|
Core U.S. origin |
Washington, D.C. metro area, Maryland, Virginia, Boston/Cambridge, New York, San Francisco Bay Area, San Diego, Houston, Research Triangle, Seattle, Los Angeles and other life-science hubs. |
|
International origin |
Global longevity ecosystem participants, including European and Asian biotech/research leaders, healthspan advocates, global investors and nonprofit/foundation executives. |
|
Geographic targeting note |
Use U.S. life sciences + D.C. policy ecosystem as Tier 1; add global longevity biotech and research organizations as Tier 2. |
4. Audience Reach
|
Reach Level |
Assessment |
|
Local |
Moderate: D.C.-area policy, nonprofit, association, government affairs and federal health stakeholders. |
|
National |
Very high: summit is designed around U.S. federal policy, Congressional engagement, healthspan legislation, NIH/ARPA-H-style research priorities and federal decision-making. |
|
Global |
Moderate to high: official copy says leaders, advocates and innovators from around the globe; the topic is global, but the strongest buying angle is U.S. policy access. |
|
Best sales positioning |
National / global niche summit for longevity science policy, not a broad public wellness expo. Small-room influence is the pearl here, not mass footfall. |
5. Sample Buyer Company Names - Buyers Only + Websites
|
Buyer Company / Org |
Website |
Apollo Industry |
Best Target Titles |
Why Good Buyer Fit |
|
FibroBiologics |
https://fibrobiologics.com |
Biotechnology |
CEO; Chief Scientific Officer; VP Government Affairs; Head of Investor Relations |
Clinical-stage longevity/regenerative medicine company publicly announced executive speaking at H-SPAN Summit; strong fit for policy and scientific visibility. |
|
BioAge Labs |
https://bioagelabs.com |
Biotechnology |
COO; CEO; VP Corporate Development; Head of Policy |
Aging-biology therapeutics company; A4LI board appointment included BioAge COO, making this ecosystem-relevant. |
|
Life Biosciences |
https://www.lifebiosciences.com |
Biotechnology |
CEO; Chief Medical Officer; VP Business Development; Head of Communications |
Longevity therapeutics company; strong need for policy, investor and clinical-translation networking. |
|
Retro Biosciences |
https://www.retrobio.com |
Biotechnology |
CEO; CSO; VP Translational Science; Head of Strategy |
Aging biology and cellular rejuvenation company; likely interested in longevity-policy visibility and research partnerships. |
|
Altos Labs |
https://altoslabs.com |
Biotechnology |
Scientific Director; VP External Affairs; Head of Partnerships |
High-profile cellular rejuvenation research company; strong fit for scientific advancement and healthspan innovation conversations. |
|
Calico Life Sciences |
https://www.calicolabs.com |
Biotechnology |
Head of Research; Translational Medicine Lead; Alliance Management |
Longevity and age-related disease research organization; strong fit for geroscience and policy/science bridge discussions. |
|
Unity Biotechnology |
https://unitybiotechnology.com |
Biotechnology |
CEO; CMO; VP Clinical Development; Corporate Development Lead |
Senolytic/age-related disease biotech buyer profile for policy, investor and BD discussions. |
|
Cambrian BioPharma |
https://www.cambrianbio.com |
Biotechnology |
CEO; Portfolio Strategy Lead; VP Business Development |
Longevity-focused biotech portfolio company; relevant to innovation policy, investment and translational science. |
|
Juvenescence |
https://www.juvlabs.com |
Biotechnology |
Partner; CEO; Business Development Director; Scientific Advisor |
Longevity investment/platform organization with broad therapeutic interest in aging biology. |
|
Insilico Medicine |
https://insilico.com |
Biotechnology / Computer Software |
VP AI Drug Discovery; Business Development Director; Government Affairs Lead |
AI-driven drug discovery company active in aging/longevity research themes. |
|
Loyal |
https://loyal.com |
Biotechnology / Veterinary |
CEO; VP Clinical; Head of Regulatory Affairs; Partnerships Lead |
Longevity therapeutics company in animal health; strong regulatory and healthspan-policy relevance. |
|
Buck Institute for Research on Aging |
https://www.buckinstitute.org |
Research |
Institute Director; Director of Partnerships; Research Program Lead |
Major aging research institute; strong scientific and policy-engagement relevance. |
|
AFAR - American Federation for Aging Research |
https://www.afar.org |
Research / Nonprofit Organization Management |
Executive Director; Program Director; Scientific Affairs Lead |
Aging research funder and convener; highly aligned with healthy aging policy and research translation. |
|
Hevolution Foundation |
https://www.hevolution.com |
Philanthropy / Biotechnology |
Program Officer; Scientific Partnerships Lead; Investment Director |
Global healthspan funder; buyer/influencer for research partnerships, policy dialogue and longevity ecosystem mapping. |
|
Milken Institute Future of Aging |
https://milkeninstitute.org |
Think Tanks |
Director - Future of Aging; Health Policy Director; Partnerships Lead |
Policy and aging-economy organization relevant to healthspan, public policy and longevity advocacy. |
6. Job Profiles, Industries & Event Type
|
Targeting Area |
Recommended Filters |
|
Best job titles to pull from Apollo |
CEO; Founder; Chief Scientific Officer; Chief Medical Officer; VP Government Affairs; Director of Federal Affairs; Head of Policy; VP Business Development; Corporate Development Director; Investor Relations Lead; Program Officer; Research Director; Public Affairs Director; Partnerships Director; Regulatory Affairs Director. |
|
Best Apollo industries |
Biotechnology; Pharmaceuticals; Research; Public Policy; Government Relations; Think Tanks; Venture Capital & Private Equity; Nonprofit Organization Management; Hospital & Health Care; Medical Devices; Health, Wellness & Fitness; Higher Education; Investment Management. |
|
Event type |
Conference / summit with science sessions, policy panels, sponsor presentations, advocacy meetings and Capitol Hill engagement. Not a mass trade expo. |
|
Seniority filter |
Prioritize C-level, Founder, Partner, VP, Director, Head, Principal Investigator, Program Officer, Government Affairs and Policy leadership. |
7. Estimated Attendance - Expected Total Footfall
|
Attendance View |
Details |
|
Official published number |
No official total attendance count found on the public 2026 A4LI H-SPAN Summit page as of research date. |
|
Published scale signals |
Third annual summit; multi-day agenda; sponsor tiers include limited complimentary passes; format includes policy sessions, sponsor presentation opportunities, VIP/sponsor meetings and Hill Day. |
|
Recommended estimate |
150-300 senior attendees / participants is a practical planning estimate for a curated D.C. policy summit. Keep this as estimated, not official. |
|
List-size expectation |
Quality is more important than volume. Strong sample lists should emphasize 30-80 premium senior contacts rather than thousands of low-fit wellness contacts. |
8. Key Focus Areas & Buyer Engagement
|
Focus Area |
Buyer Engagement Signal |
|
Longevity science and drug discovery |
Research breakthroughs, longevity-focused drug discovery, cellular therapeutics, regenerative medicine, biomarkers, AI and translational geroscience. |
|
Federal policy and funding |
NIH aging biology funding, proposed longevity research institutes, ARPA-H-style innovation, regulatory frameworks and public-health strategies for age-related disease burden. |
|
Advocacy and Hill Day |
Congressional briefing, meetings with congressional offices, policy coalition building and sponsor-led advocacy around healthspan and aging-biology legislation. |
|
Business development |
Partnerships among biotech companies, research institutes, investors, foundations, policy groups and government affairs teams. |
|
Buyer engagement style |
Sponsorship, speaking slots, policy meetings, VIP/sponsor dinners, scientific presentations, investor/BD conversations and post-summit government affairs follow-up. |
9. Client Product Review Note - Use Before Final List Pull
Before finalizing a paid attendee/buyer list, review the client website/product first. Please share the client website so the target list can be filtered by exact buyer fit. This event changes shape depending on whether the client sells biotech services, policy intelligence, investor access, lab/research tools, clinical/regulatory services, healthcare advocacy solutions or longevity products.
|
Client Product Type |
Best Buyer Direction |
|
If client sells biotech / CRO / clinical services |
Target CSO, CMO, VP Clinical Development, Translational Science, Business Development and Founder/CEO contacts at longevity biotech companies. |
|
If client sells policy / government affairs services |
Target CEOs, VP Government Affairs, Head of Policy, Public Affairs Directors and sponsor companies entering D.C. advocacy. |
|
If client sells research tools / diagnostics / biomarkers |
Target Research Directors, PI-level researchers, CSO, VP R&D, Translational Science and biomarker program leaders. |
|
If client sells investor / conference / media services |
Target VC partners, biotech CEOs, corporate development leads, investor relations, communications and partnership heads. |
10. Recommended Apollo Industry List
|
Priority |
Apollo Industries |
|
Tier 1 - strongest match |
Biotechnology; Pharmaceuticals; Research; Public Policy; Government Relations; Think Tanks; Venture Capital & Private Equity; Nonprofit Organization Management. |
|
Tier 2 - strong buyer pockets |
Hospital & Health Care; Medical Devices; Health, Wellness & Fitness; Higher Education; Investment Management; International Affairs; International Trade & Development. |
|
Tier 3 - use only if client product supports it |
Computer Software; Information Technology & Services; Management Consulting; Marketing & Advertising; Public Relations & Communications; Education Management. |
11. Research Sources Used
|
Source Type |
Source / Usage |
|
Official A4LI H-SPAN Summit page |
https://a4li.org/h-span-summit-dc/ |
|
A4LI advocacy / press page |
https://a4li.org/our-advocacy/ |
|
A4LI sponsor page |
https://a4li.org/become-a-sponsor/ |
|
Georgetown / venue cross-check |
Georgetown Capitol Campus references and event calendar cross-checks. |
|
Industry / speaker cross-checks |
Lifespan.io event listing and public company announcement for FibroBiologics speaking selection. |
Data sheet
| Event Name | A4LI H-SPAN Summit DC 2026 |
| Event Date | 29 June 2026 – 1 July 2026 |
| Event Status | Upcoming |
| Venue | Walter E. Washington Convention Center |
| City | Washington |
| State / Region | District of Columbia |
| Country | United States |
| Organizer | A4LI / H-SPAN branding referenced in supplied event brief; organizer identity not independently confirmed in publicly verified source set used for this sheet. |
| Official Event Website | Official current event page not publicly verified at time of writing. |
| Event Type | Summit / policy and networking conference |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Education & Training; Wellness, Health & Fitness; Business Services |
| Audience Reach | National, with likely federal-policy and association-level reach extending to selected international participants |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for current-year totals; supplied reference text mentions 5,000+ expected attendees, but this has not been independently verified from an official current-year source. |
| Main Purpose of Event | Policy discussion, public-health and healthcare safety dialogue, advocacy alignment, executive networking, and stakeholder engagement across healthcare, public sector, nonprofit, and industry participants. |
A4LI H-SPAN Summit DC 2026 appears to be positioned as a health policy, safety, advocacy, and professional networking summit centered on healthcare and public-health stakeholders. Based on the supplied event brief and the Washington, D.C. setting, the summit is likely to attract a mix of healthcare administrators, public-health leaders, policy professionals, government-facing organizations, advocacy groups, consultants, and solution providers with an interest in regulation, compliance, patient safety, and sector collaboration.
From a commercial perspective, the event matters because Washington, D.C. summits in this category typically concentrate decision-makers involved in public-sector engagement, healthcare operations, grants, policy influence, strategic partnerships, and health-program execution. Even where a current-year attendee directory is not publicly available, the event format suggests relevance for suppliers seeking healthcare system introductions, public-health partnership opportunities, policy-adjacent outreach, and relationship building with health associations, government-facing stakeholders, and institutional buyers.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Healthcare system executives | Hospitals, health systems, integrated delivery networks | Budget influence, strategic initiative ownership, vendor evaluation | High relevance for care delivery, safety, compliance, analytics, training, and operations suppliers |
| Public health agency leaders | Federal, state, and municipal health departments | Program design, grant-led purchasing, policy implementation | Relevant for public-health technology, education, outreach, and service-delivery vendors |
| Policy and advocacy leaders | Associations, think tanks, nonprofits, advocacy coalitions | Agenda setting, partnership influence, issue sponsorship | Useful for sponsors, research groups, communications, and program partners |
| Procurement and sourcing teams | Hospitals, agencies, nonprofits, large associations | RFP management, vendor qualification, contract administration | Direct buyer value for approved suppliers and contracting opportunities |
| Safety, quality, and compliance leaders | Healthcare providers, clinics, laboratories, public programs | Specification influence, risk and standards oversight | Strong fit for training, safety systems, audit, monitoring, and compliance vendors |
| Population health and program directors | Government programs, health plans, nonprofits, community health groups | Need-based buying tied to outreach, outcomes, and reporting | Relevant for data, engagement, education, and program-support providers |
| Health technology leaders | Provider organizations, agencies, health nonprofits | Platform selection, integration oversight, digital transformation | Important for software, cybersecurity, interoperability, and analytics firms |
| Association and membership executives | Professional bodies, convening organizations | Partnerships, sponsorship, education procurement | Useful for sponsorship sales, content partnerships, and B2B service outreach |
| Consultants and advisory firms | Health policy, healthcare strategy, compliance, public affairs consultancies | Influence on vendor shortlists and transformation projects | Can become channel partners or project introducers |
| Researchers and academic health leaders | Schools of public health, medical centers, research institutes | Grant influence, pilot programs, evidence generation | Relevant for research support, analytics, education, and innovation partnerships |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Washington, D.C. | Federal agencies, national associations, advocacy groups, health policy organizations | Very High | Core market for policy-facing healthcare and public-sector engagement |
| Maryland and Virginia | Health systems, contractors, nonprofits, life sciences and consulting firms | High | Natural feeder geography for D.C. events |
| Northeast U.S. | Hospital systems, public health schools, payers, foundations | High | Strong rail and air access to Washington supports executive attendance |
| National U.S. attendance | Healthcare systems, statewide health agencies, national nonprofits, digital health vendors | High | Likely national draw if summit includes policy, advocacy, and leadership programming |
| Selected international participants | Global NGOs, public health organizations, academic and policy representatives | Medium | Possible but not confirmed for current year |
| Reach Level | Assessment | Explanation |
|---|---|---|
| National | Primary classification | Washington, D.C. policy events in health and public affairs typically attract national associations, agency stakeholders, health systems, and advocacy networks. |
| Regional | Secondary characteristic | Strong concentration expected from the D.C.-Maryland-Virginia corridor. |
| Global | Possible but unconfirmed | International participation may occur through NGOs, public-health institutions, and policy observers, but no verified current-year list was found. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| U.S. Department of Health and Human Services | Federal health agency | Central policymaking and public-health funding body relevant to health-policy summits in Washington | hhs.gov | Program Director, Procurement Analyst, Public Health Advisor | Strong Market Fit, Attendance Not Confirmed |
| Centers for Disease Control and Prevention | Federal public health agency | Relevant for population health, safety, data, prevention, and national health program dialogue | cdc.gov | Division Director, Program Manager, Public Health Analyst | Strong Market Fit, Attendance Not Confirmed |
| Centers for Medicare & Medicaid Services | Federal payer / regulator | Influential in healthcare quality, compliance, reimbursement, and program administration | cms.gov | Center Director, Quality Director, Contracting Officer | Strong Market Fit, Attendance Not Confirmed |
| National Institutes of Health | Federal research institution | High relevance for evidence-led health initiatives, grants, innovation, and policy dialogue | nih.gov | Program Officer, Research Administrator, Operations Director | Strong Market Fit, Attendance Not Confirmed |
| American Hospital Association | National association | Health policy, advocacy, and hospital leadership alignment make it a natural stakeholder | aha.org | VP Policy, Partnerships Director, Program Director | Strong Market Fit, Attendance Not Confirmed |
| American Public Health Association | Professional association | Direct alignment with public-health leadership, education, and advocacy | apha.org | Executive Director, Program Manager, Public Affairs Director | Strong Market Fit, Attendance Not Confirmed |
| Kaiser Permanente | Integrated health system | Large buyer of care delivery, analytics, patient safety, and operational solutions | kp.org | VP Population Health, Director Quality, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Johns Hopkins Medicine | Academic health system | Regional powerhouse in clinical care, research, and policy engagement | hopkinsmedicine.org | Chief Quality Officer, Safety Director, Strategic Sourcing Manager | Strong Market Fit, Attendance Not Confirmed |
| MedStar Health | Regional health system | Strong local relevance given the D.C. market and healthcare leadership footprint | medstarhealth.org | Operations Director, Quality Director, Supply Chain Director | Strong Market Fit, Attendance Not Confirmed |
| Inova Health | Regional health system | Relevant buyer of safety, technology, and health operations services in the DMV region | inova.org | VP Operations, Sourcing Manager, Clinical Program Director | Strong Market Fit, Attendance Not Confirmed |
| District of Columbia Department of Health | Local government health agency | Direct local public-health stakeholder for a Washington-based summit | dchealth.dc.gov | Program Manager, Public Health Director, Procurement Specialist | Strong Market Fit, Attendance Not Confirmed |
| National Association of County and City Health Officials | Public health association | Relevant for local health department outreach, program partnerships, and sector visibility | naccho.org | Program Director, Partnership Manager, Public Policy Manager | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer / Chief Population Health Officer | Executive / Clinical Leadership | C-Level | Owns strategic health outcomes, policy alignment, and clinical program direction. |
| 2 | VP / Director of Public Health Programs | Programs | VP / Director | Influences vendor evaluation for program implementation and outreach initiatives. |
| 3 | Director of Quality / Patient Safety | Quality & Safety | Director | Core buyer or influencer for safety, compliance, training, and monitoring solutions. |
| 4 | Director of Government Affairs / Public Policy | Government Affairs | Director | Important in advocacy-led organizations and policy-partnering decisions. |
| 5 | Procurement Manager / Strategic Sourcing Manager | Procurement | Manager | Direct purchasing control for approved products and contracted services. |
| 6 | Contracting Officer / Grants & Contracts Manager | Contracts | Manager / Director | Key contact for public-sector and institutional acquisition pathways. |
| 7 | Chief Information Officer / IT Director | Information Technology | C-Level / Director | Relevant where the event includes digital health, interoperability, analytics, or cybersecurity themes. |
| 8 | Operations Director | Operations | Director | Owns implementation, process change, workforce coordination, and deployment feasibility. |
| 9 | Partnerships Director | Partnerships / External Affairs | Director | Crucial for sponsorships, pilots, coalition building, and cross-sector collaboration. |
| 10 | Program Manager | Programs / Operations | Manager | Frequent evaluator and day-to-day operator for services, systems, and grant-supported projects. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core provider audience fit | Clinical operations, quality, safety, patient engagement |
| 2 | Government Administration | Relevant for public-health agencies and health departments | Program procurement, grants, public services |
| 3 | Nonprofit Organization Management | Advocacy groups and health nonprofits are likely attendees | Programs, campaigns, community partnerships |
| 4 | Public Policy | Washington policy ecosystem alignment | Advocacy, coalition building, thought leadership |
| 5 | Medical Devices | Relevant where safety, patient monitoring, and care delivery tools are discussed | Clinical device adoption, safety workflow solutions |
| 6 | Information Technology & Services | Common fit for health data, compliance, and program management platforms | Software, reporting, analytics, integrations |
| 7 | Computer Software | Useful for digital health and workflow enablement vendors | Program software, dashboards, compliance platforms |
| 8 | Research | Academic and evidence-based stakeholders fit this event profile | Research partnerships, pilots, evaluation tools |
| 9 | Higher Education | Schools of public health and academic medicine may participate | Training, public-health research, grant activity |
| 10 | Management Consulting | Consultants often influence policy, operational redesign, and vendor selection | Implementation and advisory partnerships |
| 11 | Government Relations | Advocacy and association ecosystem alignment | Policy communications, coalition support |
| 12 | Pharmaceuticals | Possible relevance in public-health and policy dialogue | Access, education, partnerships, safety programs |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | 5,000+ referenced | Estimated | Supplied event brief | Not publicly confirmed by the organizer in independently verified current-year material. |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No verified exhibitor prospectus or directory located | Could change if event page is released later. |
| Buyer count | Not publicly confirmed | Unconfirmed | No verified attendee segmentation report located | Buyer mix is inferred from summit theme and venue market context. |
| Speaker count | Not publicly confirmed | Unconfirmed | No verified agenda located | Speaker organizations would improve targeting if released. |
| Sponsor count | Not publicly confirmed | Unconfirmed | No verified sponsor page located | Sponsorship footprint may indicate commercial maturity. |
| Historical attendance | No independently verified prior-year figure located | Historical / prior-year evidence unavailable | Publicly accessible prior-year attendance evidence not confirmed | Use caution in forecasting list size. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Health policy | Guidance on regulation, compliance, reimbursement, and program priorities | Thought leadership, policy briefings, executive introductions | Advisory, policy intelligence, communications support |
| Patient safety and quality | Risk reduction, outcomes improvement, standards compliance | Demonstrations, case studies, pilot opportunities | Safety systems, training, audit tools, monitoring solutions |
| Public health programs | Community outreach, prevention, education, reporting | Program design conversations, grants alignment | Engagement platforms, analytics, communication tools |
| Healthcare operations | Efficiency, staffing support, workflow modernization | Operational ROI discussions | Workflow software, staffing support services, implementation consulting |
| Digital transformation | Interoperability, data visibility, system modernization | IT and program leadership meetings | Software platforms, integration services, analytics tools |
| Advocacy and partnerships | Coalition support, stakeholder alignment, sponsorship value | Association and nonprofit partnership outreach | Sponsorship, campaign support, strategic partnerships |
| Data and reporting | Measurement, compliance documentation, outcomes tracking | Dashboard and evidence-based solution positioning | BI, reporting, survey, research and evaluation services |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Health policy, provider, public-health, and nonprofit audiences are commercially meaningful for specialized B2B solutions. |
| Decision-maker availability | Medium to High | Summit format suggests director-and-above participation, but current-year speaker and attendee proof is limited. |
| Data collection potential | Medium | Useful if sponsorship, registration partnerships, speaker lists, or attendee networking tools become available. |
| Apollo targeting potential | High | Industries, geographies, and titles are highly targetable in Apollo even without a verified attendee list. |
| Geographic targeting potential | Very High | D.C., Maryland, Virginia, and national healthcare hubs are easy to isolate. |
| Best outreach approach | High | Use policy relevance, program outcomes, grants alignment, and safety/compliance ROI messaging. |
| Overall lead quality | High | Good fit for healthcare, policy, public-health, and institutional B2B sellers. |
| Best use case | B2B attendee list building and account-based prospecting | Best used as an account-prioritization and outreach trigger rather than a guaranteed attendee list. |
| Limitations / risks | Medium | Organizer, official website, agenda, and attendance statistics were not independently confirmed; treat all non-official list-building as inferred prospecting. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Government Administration; Nonprofit Organization Management; Public Policy; Medical Devices; Information Technology & Services; Computer Software; Research; Higher Education; Management Consulting; Government Relations; Pharmaceuticals | Captures likely provider, public-health, policy, association, and supporting vendor ecosystems |
| Departments | Operations; Information Technology; Purchasing; Program Management; Quality; Government Affairs; Partnerships; Executive | Focuses on direct buyers and key internal influencers |
| Seniority | C-Level; VP; Director; Head; Manager | Balances strategic access with practical buying control |
| Job titles | Chief Medical Officer; Chief Population Health Officer; Director of Quality; Director of Patient Safety; Director of Public Health; Procurement Manager; Strategic Sourcing Manager; Contracting Officer; Program Director; Operations Director; CIO; IT Director; Director of Government Affairs; Partnerships Director | High-fit role list for outreach and attendee-matching |
| Geography | Washington, DC; Maryland; Virginia; Northeast U.S.; United States | Prioritizes event-local plus national expansion |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Covers associations, nonprofits, agencies, and enterprise health systems |
| Keywords | public health, patient safety, quality improvement, health policy, healthcare compliance, population health, government affairs, healthcare operations, community health, care coordination | Improves theme-based precision beyond industry filters alone |
| Technologies, if relevant | EHR, analytics, CRM, telehealth, workflow automation, interoperability | Useful if client sells software, data, or implementation services |
| Revenue range, if relevant | $10M–$50M; $50M–$500M; $500M+ | Supports prioritization of organizations with budget depth |
| Company type | Nonprofit; Public Sector; Private; Academic / Research | Reflects the probable attendee mix for this summit theme |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| User-supplied event brief | Provided reference text | Event title, venue naming, thematic description, and unverified expected attendance reference | Medium; useful as a working brief but not equivalent to an official organizer source |
| Walter E. Washington Convention Center – Events DC | Official venue website | Venue identity and location context | High for venue information |
| No official current-year event website, agenda, exhibitor list, sponsor page, or attendee directory publicly verified in the source set used for this report | Verification note | Explains why organizer, attendance, speaker count, and confirmed participant table entries remain unverified | High as a transparency note |
| Date discrepancy note | Verification note | Known event details supplied by the user indicate 29 June 2026 – 1 July 2026, while the embedded reference description states 14–16 April 2026. This sheet uses the known details supplied in the request. | High as a documented input discrepancy |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to A4LI H-SPAN Summit Washington, DC 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.